Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
Relative oxidation-reduction potentials of heme groups in two soluble doubleheme proteins.
The Neuronal alpha-bungarotoxin Binding Site
See All 3 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password